Mitoxantrone in combination with an inhibitor of DNA-dependent protein kinase: A potential therapy for poor risk B-cell chronic lymphocytic leukaemia

被引：0
|
作者：
Elliott, S. L. [1 ]
Crawford, C. W. [1 ]
Summerfield, G. P. [2 ]
Newton, P. [3 ]
Wallis, J. [2 ]
Mainou-Fowler, T. [2 ]
Evans, P. [4 ]
Bedwell, C. [5 ]
Durkacz, B. W. [1 ]
Willmore, E. [1 ]
机构：
[1] Univ Newcastle, No Inst Canc Res, Newcastle Upon Tyne, Tyne & Wear, England
[2] Univ Newcastle, Dept Acad Haematol, Newcastle Upon Tyne, Tyne & Wear, England
[3] Sunderland Royal Hosp, Sunderland, England
[4] St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England
[5] Newcastle Tyne NHS Hosp Trust, No Genet Serv, Newcastle Upon Tyne, Tyne & Wear, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2010年 / 149卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
227
引用
收藏
页码：90 / 90
页数：1
相关论文
共 50 条
  • [31] Fulminant B hepatitis in a surface antigen-negative patient with B-cell chronic lymphocytic leukaemia after rituximab therapy
    P Niscola
    M I Del Principe
    L Maurillo
    A Venditti
    F Buccisano
    D Piccioni
    S Amadori
    G Del Poeta
    Leukemia, 2005, 19 : 1840 - 1841
  • [32] Nuclear protein p44 - Potential marker of B-cell chronic lymphocytic leukemia
    Blonski, JZ
    Chrucciel, J
    Niewiadomska, H
    Szymczyk, P
    Robak, T
    Kilianska, ZM
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 127 - 127
  • [33] Potentiation of topoisomerase II poison cytotoxicity in the K562 human leukaemia cell line by the novel DNA-dependent protein kinase inhibitor NU7026
    Willmore, E
    Tilby, MJ
    Austin, CA
    Durkacz, BW
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S26 - S26
  • [34] Venetoclax for chronic lymphocytic leukaemia patients who progress after more than one B-cell receptor pathway inhibitor
    Wierda, William G.
    Byrd, John C.
    Davids, Matthew S.
    Furman, Richard R.
    Cheson, Bruce D.
    Barr, Paul M.
    Eradat, Herbert
    Heffner, Leonard
    Zhou, Lang
    Verdugo, Maria
    Potluri, Jalaja
    Choi, Michael
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (05) : 961 - 966
  • [35] Effects of CD20 antibodies and kinase inhibitors on B-cell receptor signalling and survival of chronic lymphocytic leukaemia cells
    Cavallini, Chiara
    Galasso, Marilisa
    Dalla Pozza, Elisa
    Chignola, Roberto
    Lovato, Ornella
    Dando, Ilaria
    Romanelli, Maria G.
    Krampera, Mauro
    Pizzolo, Giovanni
    Donadelli, Massimo
    Scupoli, Maria T.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 192 (02) : 333 - 342
  • [36] Regulation of Akt/PKB by phosphatidylinositol 3-kinase-dependent and -independent pathways in B-cell chronic lymphocytic leukemia cells:: role of protein kinase Cβ
    Barragan, Montserrat
    de Frias, Merce
    Iglesias-Serret, Daniel
    Campas, Clara
    Castano, Esther
    Santidrian, Antonio F.
    Coll-Mulet, Llorenc
    Cosialls, Ana M.
    Domingo, Alicia
    Pons, Gabriel
    Gil, Joan
    JOURNAL OF LEUKOCYTE BIOLOGY, 2006, 80 (06) : 1473 - 1479
  • [37] Efficacy and Tolerability Of Frontline Oral Fludarabine and Cyclophosphamide Combination Therapy For Elderly Patients With Chronic B-Cell Lymphocytic Leukaemia and Low Grade Non Hodgkin Lymphoma
    Bergamaschi, Micaela
    Mitscheunig, Laura
    Guolo, Fabio
    Ghiso, Anna
    Galaverna, Federica
    Miglino, Maurizio
    Clavio, Marino
    Ballerini, Filippo
    Canepa, Letizia
    Lemoli, Roberto
    Gobbi, Marco
    Pierri, Ivana
    BLOOD, 2013, 122 (21)
  • [38] Preclinical characterization of VX-984, a selective DNA-dependent protein kinase (DNA-PK) inhibitor in combination with doxorubicin in breast and ovarian cancers
    Boucher, D.
    Newsome, D.
    Takemoto, D.
    Hillier, S.
    Wang, Y.
    Arimoto, R.
    Maxwell, J.
    Charifson, P.
    Fields, S. Z.
    Tanner, K.
    Penney, M. S.
    CANCER RESEARCH, 2017, 77
  • [39] Involvement of protein kinase C and phosphatidylinositol 3-kinase pathways in the survival of B-cell chronic lymphocytic leukemia cells
    Barragan, M
    Bellosillo, B
    Campàs, C
    Colomer, D
    Pons, G
    Gil, J
    BLOOD, 2002, 99 (08) : 2969 - 2976
  • [40] B-cell chronic lymphocytic leukaemia cells show specific changes in membrane protein expression during different stages of cell cycle
    Bennett, Fiona
    Rawstron, Andy
    Plummer, Marieth
    de Tute, Ruth
    Moreton, Paul
    Jack, Andrew
    Hillmen, Peter
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 139 (04) : 600 - 604
12345